NCT03781505View on ClinicalTrials.gov

Intravenous Paracetamol in Combination With Caudal Ropivacaine

PHASE4CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

January 31, 2019

Primary Completion Date

April 30, 2022

Study Completion Date

May 1, 2022

Conditions
Postoperative Analgesia
Interventions
DRUG

Paracetamol +caudal ropivacaine

Paracetamol + Ropivacaine

DRUG

Placebo

Caudal ropivacaine

Trial Locations (1)

74800

Aga Khan University Hospital, Karachi

All Listed Sponsors
lead

Aga Khan University

OTHER

NCT03781505 - Intravenous Paracetamol in Combination With Caudal Ropivacaine | Biotech Hunter | Biotech Hunter